Top-News
Biotechnologie USA

Opus Genetics Inc Aktie

Aktie
WKN:  A2QG4Z ISIN:  US67577R1023 US-Symbol:  IRD
1,112 €
-0,064 €
-5,44%
21:14:20 Uhr
Depot/Watchlist
Aktienanzahl *
31,44 Mio.
Marktkapitalisierung *
36,94 Mio. €
Streubesitz
85,19%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 06.11.2024

Opus Genetics Inc News

25.10.24 - PR Newswire
The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics
The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics PR Newswire
27.09.23 - PR Newswire
Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g., Tropicamide) Agents
Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-​Induced Mydriasis ...
24.11.21 - PR Newswire
Thinking about buying stock in Ocuphire Pharma, Seelos Therapeutics, Anavex Life Sciences, Leap Therapeutics, or Oramed Pharmaceuticals?
Thinking about buying stock in Ocuphire Pharma, Seelos Therapeutics, Anavex Life Sciences, Leap Therapeutics, or Oramed Pharmaceuticals? PR Newswire
30.06.21 - PR Newswire
Thinking about buying stock in Weidai, Ocuphire Pharma, AST SpaceMobile, Vertex Energy, or SoFi Technologies?
Thinking about buying stock in Weidai, Ocuphire Pharma, AST SpaceMobile, Vertex Energy, or SoFi Technologies? PR Newswire
15.10.20 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, REXN, and WPX Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, REXN, and WPX Shareholders About Its Ongoing Investigations PR Newswire
20.05.13 - PR Newswire
Rexahn Pharmaceuticals To Present At The Second Annual Marcum LLP MicroCap Conference
Rexahn Pharmaceuticals To Present At The Second Annual Marcum LLP MicroCap Conference PR Newswire
16.06.11 - Aktiencheck
Rexahn Pharmaceuticals "buy" - Brean Murray, Carret & Co
Rating-​Update: New York (aktiencheck.de AG) - Die Analysten von Brean Murray, Carret & Co nehmen die Coverage für die Aktie von Rexahn Pharmaceuticals mit "buy" wieder auf. ...

Newssuche

Videos

newspaper
06.02.25
Technical Trading: Gold Allzeithoch!
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »